Telik Announces 2008 Second Quarter Financial Release, Conference Call a... ( PALO ALTO Calif. Aug. 4 /- Telik ...)

Telik Announces 2008 Second Quarter Financial Release, Conference Call and Webcast

Date:8/4/2008

PALO ALTO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Telik, Inc. (Nasdaq: TELK) announced that its 2008 second quarter conference call and webcast will be held on Monday, August 11, 2008 at 4:30 p.m. Eastern time (1:30 p.m. Pacific time) following the release earlier that day of the company's financial results for the second quarter ended June 30, 2008.

The conference call will be accessible via Telik's website at http://www.telik.com or by telephone at 800-553-5260 or 612-332-0720. An archive of the conference call will be available on the Telik website or by telephone at 800-475-6701 or 320-365-3844, access code 956079. The archive will be available from approximately 6:30 p.m. Eastern time on August 11 through August 25, 2008.

Telik, Inc. of Palo Alto, CA, is a biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. The company's most advanced investigational drug candidates in clinical development are TELINTRA(R), a modified glutathione analog for the treatment of cytopenias due to myelodysplastic syndrome or chemotherapy, and TELCYTA(R), a tumor-activated prodrug for the treatment of advanced ovarian cancer and non-small cell lung cancer. Telik's product candidates were discovered using its proprietary drug discovery technology, TRAP(R), which enables the rapid and efficient discovery of small molecule drug candidates.

TELIK, the Telik logo, TELINTRA, TELCYTA and TRAP are trademarks or registered trademarks of Telik, Inc.

SOURCE Telik, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Post Your Comments:

(Date:5/17/2013)... USA (PRWEB) May 17, 2013 • First ... Globes Certified for sustainability , New facility will ... , Syngenta unveiled its new ... at the company’s RTP Innovation Center. The first of ... researchers to simulate any agricultural climate and precisely measure ...

(Date:5/17/2013)... 2013 /PRNewswire-iReach/ -- Aridis is pleased to announce ... Switzerland -based Kenta Biotech to acquire ... (mAb) products, and technologies. This asset portfolio purchase ... of infections by common pathogens including drug resistant ... Pseudomonas aeruginosa , Acinetobacter baumannii and ...

(Date:5/17/2013)... May 17, 2013 RURO Inc. ... version 4.1, a versatile refinement to the smart ... solution, improves its advanced methodical management for transgenic ... ezColony 4.1. The network-based platform provides user access ... research. While continuing to emphasize streamlined tasks, such ...

(Date:5/16/2013)... (PRWEB) May 16, 2013 The ... by Global Cooling, Inc., Athens, OH, USA, won the ... by the International Society for Biological and Environmental Repositories ... award, given to one product annually, recognizes the company’s ... ultra-low temperature freezer. The award was presented to ...

Breaking Biology Technology:Syngenta Opens Unique $72 Million Advanced Crop Lab 2 Syngenta Opens Unique $72 Million Advanced Crop Lab 3 Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 2 Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech 3 RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software 2 Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia 2

[0] Syngenta Opens Unique $72 Million Advanced Crop Lab [0] Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech [0] RURO Introduces ezColony 4.1 – The Versatile Transgenic Animal Colony Management Software [0] Stirling Ultracold Ultra-Low Freezer Wins 2013 Outstanding New Product Award at International Biorepository Conference, Sydney, Australia

... PXS, Nasdaq: PXSL) today announced that its Phase ... people with bronchiectasis has met its two,primary efficacy ... Data from the 362 subject study demonstrated a ... weeks of treatment with Bronchitol,as assessed by the ...

... ... - Company ... BioPharma, Inc.,(PDL) (Nasdaq: PDLI ) today announced a significant strategic ... antibodies in,oncology and select immunological diseases, following a months-long,business and portfolio ...

... - Plan Extends Financial Resources Beyond 2008 -, ... Sunesis,Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced ... percent, and implementing a revised,operating plan that focuses ... programs while streamlining the company,s operations and extending,its ...

Cached Biology Technology:Phase III Trial Finds Pharmaxis' Bronchitol Effective 2 Phase III Trial Finds Pharmaxis' Bronchitol Effective 3 PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 2 PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 3 PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 4 PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development 5 Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 2 Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 3 Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs 4

Phase III Trial Finds Pharmaxis' Bronchitol Effective PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs

(Date:5/16/2013)... Philadelphia, PA, May 16, 2013 The relationship ... intelligence (IQ) has not been clear. Schizophrenia is ... functional disability. There are clues that reduced IQ ... schizophrenia. For example, reduced cognitive ability may precede ... may be present in healthy relatives of people ...

(Date:5/16/2013)... May 16, 2013 Integrated Biometrics patented ... a custom thin film transistor camera introduces Sherlock, ... roll image in the smallest and lightest form ... Appendix F Mobile ID FAP 45, Certified scanner ... in size and weight when compared to optical ...

(Date:5/16/2013)... about 23 million years old give unprecedented insight ... one of the most species-rich groups among the ... Professor Bettina Reichenbacher from the Division of Paleontology ... Environmental Sciences at Ludwig-Maximilians-Universitaet (LMU) in Munich / ... fossils which they assign to the group of ...

Breaking Biology News(10 mins):Genetic risk for schizophrenia is connected to reduced IQ 2 Paleontology: The eloquence of the otoliths 2 Paleontology: The eloquence of the otoliths 3

[0] Genetic risk for schizophrenia is connected to reduced IQ [0] Integrated Biometrics Introduces Sherlock [0] Paleontology: The eloquence of the otoliths

... This release is available in German . , ... in Geoscience on 10 October 2010. With the prize, which ... the 100th anniversary of the Geologische Vereinigung (GV) in Frankfurt ... the junior professor at the Alfred Wegener Institute and the ...

... Medical Center has been named one of five ... find new gene and cell therapies for inherited ... of Diabetes, Digestive and Kidney Diseases, one of ... five-year, $3.4 million grant for Cincinnati Children,s to ...

... its 2010 awards. Professional awards will be presented at the ... Diego, California, Sunday, December 12, 5:30-7:30 p.m. The student awards ... awardees are listed below. HONORARY MEMBERSHonorary ... 20 years through significant involvement in the affairs of the ...

2010 Albert Maucher Prize awarded to Potsdam palaeoclimatologist NIH funds Center of Excellence for Molecular Hematology at Cincinnati Children's Entomological Society of America names 2010 Insect Science Award winners

Recommend to use at up to 5000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...

... purified from egg white. The extinction coefficient , ... in 10 mM phosphate-buffered saline, pH ... sodium azide and 50% glycerol. Avidin (from egg ... is purified by molecular sieving and ...

... The Zero Blunt TOPO ... Sequencing is designed for ... of blunt-end PCR products. ... 5-minute TOPO Cloning and ...

Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...

Biology Products:

Caspase-8 Inhibitor Z-IETD-FMK from BioVision Avidin, FITC conjugated/tagged from Invitrogen Zero Blunt TOPO PCR Cloning Kit for Sequencing with One Shot TOP10 Electrocomp E. coli from Invitrogen Caspase-6 Inhibitor Z-VEID-FMK from BioVision